
Cassel Salpeter & Co.’s Q3 healthcare update points to disrupted NIH grant processing, FDA attrition, and tariffs as pressures on drug development and early-stage financing.
In the January issue of Applied Clinical Trials, an author was inadvertently omitted from the article "Seeking Guidance on Rater Reliability."
Marian A. Ormont, M.D., F.A.P.M., Medical Director of ePharmaSolutions, email: mormont@epharmasolutions.com, was co-author to this article. Dr. Ormont recently joined ePharmaSolutions to support the company's expansion of its global CNS Rater Services Department.
Applied Clinical Trials sincerely regrets this error.






